147 related articles for article (PubMed ID: 38802689)
1. Cardiac comorbidities in McArdle disease: case report and systematic review.
Hoxhaj D; Vadi G; Bianchi L; Fontanelli L; Torri F; Siciliano G; Ricci G
Neurol Sci; 2024 May; ():. PubMed ID: 38802689
[TBL] [Abstract][Full Text] [Related]
2. Differential glucose metabolism in mice and humans affected by McArdle disease.
Krag TO; Pinós T; Nielsen TL; Duran J; García-Rocha M; Andreu AL; Vissing J
Am J Physiol Regul Integr Comp Physiol; 2016 Aug; 311(2):R307-14. PubMed ID: 27280431
[TBL] [Abstract][Full Text] [Related]
3. Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Krag TO; Pinós T; Nielsen TL; Brull A; Andreu AL; Vissing J
J Neuropathol Exp Neurol; 2016 May; 75(5):441-54. PubMed ID: 27030740
[TBL] [Abstract][Full Text] [Related]
4. Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC).
Scalco RS; Lucia A; Santalla A; Martinuzzi A; Vavla M; Reni G; Toscano A; Musumeci O; Voermans NC; Kouwenberg CV; Laforêt P; San-Millán B; Vieitez I; Siciliano G; Kühnle E; Trost R; Sacconi S; Stemmerik MG; Durmus H; Kierdaszuk B; Wakelin A; Andreu AL; Pinós T; Marti R; Quinlivan R; Vissing J;
Orphanet J Rare Dis; 2020 Nov; 15(1):330. PubMed ID: 33234167
[TBL] [Abstract][Full Text] [Related]
5. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
Vissing J; Duno M; Schwartz M; Haller RG
Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
[TBL] [Abstract][Full Text] [Related]
6. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
[TBL] [Abstract][Full Text] [Related]
7. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
[TBL] [Abstract][Full Text] [Related]
8. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
Haller RG; Vissing J
Arch Neurol; 2002 Sep; 59(9):1395-402. PubMed ID: 12223025
[TBL] [Abstract][Full Text] [Related]
10. McArdle disease: a case report and review.
Leite A; Oliveira N; Rocha M
Int Med Case Rep J; 2012; 5():1-4. PubMed ID: 23754915
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy.
Delaney NF; Sharma R; Tadvalkar L; Clish CB; Haller RG; Mootha VK
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8402-8407. PubMed ID: 28716914
[TBL] [Abstract][Full Text] [Related]
12. McArdle disease in a patient with anorexia nervosa: a case report.
Dalle Grave R; Patacca E; Conti M; Soave F; Dametti L; Dalle Grave A; Calugi S
Eat Weight Disord; 2022 Dec; 27(8):3793-3796. PubMed ID: 35871462
[TBL] [Abstract][Full Text] [Related]
13. McArdle disease: 2 case reports.
Diez Morrondo C; Pantoja Zarza L; San Millán Tejado B
Reumatol Clin; 2016; 12(3):161-3. PubMed ID: 26235145
[TBL] [Abstract][Full Text] [Related]
14. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?
Villarreal-Salazar M; Santalla A; Real-Martínez A; Nogales-Gadea G; Valenzuela PL; Fiuza-Luces C; Andreu AL; Rodríguez-Aguilera JC; Martín MA; Arenas J; Vissing J; Lucia A; Krag TO; Pinós T
Mol Metab; 2022 Dec; 66():101648. PubMed ID: 36455789
[TBL] [Abstract][Full Text] [Related]
15. Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
Fiuza-Luces C; Santos-Lozano A; Llavero F; Campo R; Nogales-Gadea G; Díez-Bermejo J; Baladrón C; González-Murillo Á; Arenas J; Martín MA; Andreu AL; Pinós T; Gálvez BG; López JA; Vázquez J; Zugaza JL; Lucia A
J Physiol; 2018 Mar; 596(6):1035-1061. PubMed ID: 29315579
[TBL] [Abstract][Full Text] [Related]
16. Clinical Presentation and Management of Severe Acute Renal Failure in McArdle Disease.
Hamadeh M; Nasrallah K; Ajami Z; Zeaiter R; Abbas L; Hamadeh S; Fares J
Clin Med Res; 2021 Jun; 19(2):90-93. PubMed ID: 33985978
[TBL] [Abstract][Full Text] [Related]
17. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
